Validation of COMPAT-SF Spanish Translation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jeff Wilson
- Phone Number: 2149471279
- Email: JeffreyWilson@mhd.com
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Recruiting
- Methodist Dallas Medical Center- Clinical Research Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years or older in age
- Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
- Able to read and understand the study information in Spanish
- Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
- Subject is willing and able to comply with the scheduled questionnaires
Exclusion Criteria:
- Subjects who do not meet the criteria in section 4.1
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Face validity:
Time Frame: through study completion, up to 18 months
|
Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire
|
through study completion, up to 18 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 009.GID.2024.D
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.